Biopsy Versus Subtotal Versus Gross Total Resection in Patients with Low-Grade Glioma: A Systematic Review and Meta-Analysis

Kaiyun Yang, Siddharth Nath, Alex Koziarz, Jetan H. Badhiwala, Huphy Ghayur, Michel Sourour, Dragos Catana, Farshad Nassiri, Mazen B. Alotaibi, Michelle Kameda-Smith, Branavan Manoranjan, Mohammed H. Aref, Seyed Alireza Mansouri, Sheila Singh, Saleh A. Almenawer

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Background: The role of the extent of surgical resection (EOR) in clinical outcomes for patients with low-grade glioma requires further examination. The goal of the present study was to evaluate the association between variable degrees of EOR and clinical outcomes for patients with low-grade glioma. Methods: We conducted a systematic review and meta-analysis and searched databases for reports of low-grade glioma EOR. Eligible studies compared patient outcomes, including ≥2 categories of EOR (biopsy, resection of any extent, subtotal resection [STR], or gross total resection [GTR]). Treatment effects were evaluated using pooled estimates, mean differences, or risk ratios (RRs) with corresponding 95% confidence intervals (CIs) using random effects modeling. Results: Our literature search yielded 60 studies with 13,289 patients. Pooled estimates of overall survival (OS) showed an increase from 3.79 years in the biopsy group to 6.68 years in STR to 10.65 years in GTR. OS was favorable with resection of any extent compared with (mean difference, 3.24; 95% CI, 0.64–5.84; P = 0.015). Pooled estimates of seizure control showed an improvement from 47.8% with biopsy to 54.2% with STR and 81.0% with GTR. Compared with STR, GTR delayed malignant transformation (RR, 0.43; 95% CI, 0.20–0.93; P = 0.032), without increasing postoperative mortality (RR, 0.38; 95% CI, 0.07–1.97; P = 0.250) or morbidity (RR, 1.22; 95% CI, 0.65–2.28; P = 0.540). Conclusion: Among patients with low-grade gliomas, greater degrees of safe EOR were associated with longer OS and progression-free survival, better seizure control, and delayed malignant transformation, without increasing mortality or morbidity.

Original languageEnglish (US)
Pages (from-to)e762-e775
JournalWorld neurosurgery
Volume120
DOIs
StatePublished - Dec 2018

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Biopsy Versus Subtotal Versus Gross Total Resection in Patients with Low-Grade Glioma: A Systematic Review and Meta-Analysis'. Together they form a unique fingerprint.

  • Cite this

    Yang, K., Nath, S., Koziarz, A., Badhiwala, J. H., Ghayur, H., Sourour, M., Catana, D., Nassiri, F., Alotaibi, M. B., Kameda-Smith, M., Manoranjan, B., Aref, M. H., Mansouri, S. A., Singh, S., & Almenawer, S. A. (2018). Biopsy Versus Subtotal Versus Gross Total Resection in Patients with Low-Grade Glioma: A Systematic Review and Meta-Analysis. World neurosurgery, 120, e762-e775. https://doi.org/10.1016/j.wneu.2018.08.163